Abstract
In haematopoietic malignancies the MLL gene, located on chromosome 11q23, is frequently disrupted by chromosome rearrangement, generally resulting in fusion to various partner genes. We have previously reported a t(11;15)(q23;q14) in a case of acute myeloblastic leukaemia. Here, we report the cloning of a novel MLL partner, AF15q14, at chromosome 15q14. In this translocation, the breakpoint occurred in exon 8 of MLL and exon 10 of AF15q14. The normal AF15q14 transcripts of approximately 8.5 kb in size, are expressed in different tumoral cell lines, in a variety of normal tissues, and in all the foetal tissues tested. Sequencing of AF15q14 cDNA revealed a putative open reading frame of 1833 amino acids that had no homology with any other known protein. The C-terminal end of the putative AF15q14 contained a bipartite nuclear localization site. The translocation t(11;15) preserved the open reading frame between MLL and the 3′ end of AF15q14. The contribution of AF15q14 to the fusion protein was only 85 amino acids. Immunofluorescence staining experiments with expression vectors encoding these 85 amino acids confirmed the functionality of the predicted nuclear localization site.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Archimbaud E, Charrin C, Magaud JP, Campos L, Thomas X, Fiere D and Rimokh R. . 1998 Leukemia 12: 25–33.
Corral J, Lavenir I, Impey H, Warren AJ, Forster A, Larson TA, Bel S, McKenzie AN, King G and Rabbitts TH. . 1996 Cell 85: 853–861.
Dimartino JF and Cleary ML. . 1999 Br. J. Haematol. 106: 614–626.
Dobson CL, Warren AJ, Pannell R, Forster A and Rabbitts TH. . 2000 EMBO J. 19: 843–851.
Fidanza V, Melotti P, Yano T, Nakamura T, Bradley A, Canaani E, Calabretta B and Croce CM. . 1996 Cancer Res. 56: 1179–1183.
Geourjon C and Deleage G. . 1995 J. Mol. Graph. 13: 209–212, 199–200.
Gu Y, Alder H, Nakamura T, Schichman SA, Prasad R, Canaani O, Saito H, Croce CM and Canaani E. . 1994 Cancer Res. 54: 2326–2330.
Gu Y, Nakamura T, Alder H, Prasad R, Canaani O, Cimino G, Croce CM and Canaani E. . 1992 Cell 71: 701–708.
Harrison CJ, Cuneo A, Clark R, Johansson B, Lafage-Pochitaloff M, Mugneret F, Moorman AV and Secker-Walker LM. . 1998 Leukemia 12: 811–822.
Hernandez JM, Mecucci C, Beverloo HB, Selleri L, Wlodarska I, Stul M, Michaux L, Verhoef G, Van Orshoven A, Cassiman JJ, Evans GA, Hagemeijer A and Van Den Berghe H. . 1995 Leukemia 9: 1162–1166.
Hunger SP, Tkachuk DC, Amylon MD, Link MP, Carroll AJ, Welborn JL, Willman CL and Cleary ML. . 1993 Blood 81: 3197–3203.
Joh T, Yamamoto K, Kagami Y, Kakuda H, Sato T, Yamamoto T, Takahashi T, Ueda R, Kaibuchi K and Seto M. . 1997 Oncogene 15: 1681–1687.
Kozak M. . 1986 Cell 44: 283–292.
Marschalek R, Nilson I, Lochner K, Greim R, Siegler G, Greil J, Beck JD and Fey GH. . 1997 Leuk. Lymphoma. 27: 417–428.
Rogaia D, Grignani F, Carbone R, Riganelli D, LoCoco F, Nakamura T, Croce CM, Di Fiore PP and Pelicci PG. . 1997 Cancer Res. 57: 799–802.
Rouault JP, Prevot D, Berthet C, Birot AM, Billaud M, Magaud JP and Corbo L. . 1998 J. Biol. Chem. 273: 22563–22569.
Rowley JD. . 1992 Genes Chromosomes Cancer 5: 264–266.
Rubnitz JE, Link MP, Shuster JJ, Carroll AJ, Hakami N, Frankel LS, Pullen DJ and Cleary ML. . 1994 Blood 84: 570–573.
Schreiner SA, Garcia-Cuellar MP, Fey GH and Slany RK. . 1999 Leukemia 13: 1525–1533.
Tkachuk DC, Kohler S and Cleary ML. . 1992 Cell 71: 691–700.
Yu BD, Hess JL, Horning SE, Brown GA and Korsmeyer SJ. . 1995 Nature 378: 505–508.
Acknowledgements
The authors wish to thank Bénédicte Santa-Lucia and Annick Bertholin for their technical assistance. This work was supported by grants from INSERM, the Association pour la Recherche contre le Cancer and the Ligue Nationale contre le Cancer (Comités du Rhône et de la Saône et Loire).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hayette, S., Tigaud, I., Vanier, A. et al. AF15q14, a novel partner gene fused to the MLL gene in an acute myeloid leukaemia with a t(11;15)(q23;q14). Oncogene 19, 4446–4450 (2000). https://doi.org/10.1038/sj.onc.1203789
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203789
Keywords
This article is cited by
-
Inhibiting microcephaly genes as alternative to microtubule targeting agents to treat brain tumors
Cell Death & Disease (2021)
-
Targeted Knockdown of the Kinetochore Protein D40/Knl-1 Inhibits Human Cancer in a p53 Status-Independent Manner
Scientific Reports (2015)
-
KNL1: bringing order to the kinetochore
Chromosoma (2014)
-
SEPT2 is a new fusion partner of MLL in acute myeloid leukemia with t(2;11)(q37;q23)
Oncogene (2006)
-
Characterization of the MLL partner gene AF15q14 involved in t(11;15)(q23;q14)
Oncogene (2003)